The following urinary biomarker combination was identified for the detection of BC in females: IL-12p70, IL-13, midkine and clusterin: AUROC 0.865 (95%CI 0.806-0.924) (sensitivity 83.7%, specificity 80.4%). This evidence concerns the gene CLU and breast cancer.